pubmed-article:1138641 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:1138641 | lifeskim:mentions | umls-concept:C0014124 | lld:lifeskim |
pubmed-article:1138641 | lifeskim:mentions | umls-concept:C0036982 | lld:lifeskim |
pubmed-article:1138641 | lifeskim:mentions | umls-concept:C0456603 | lld:lifeskim |
pubmed-article:1138641 | lifeskim:mentions | umls-concept:C1261322 | lld:lifeskim |
pubmed-article:1138641 | lifeskim:mentions | umls-concept:C1959583 | lld:lifeskim |
pubmed-article:1138641 | lifeskim:mentions | umls-concept:C0439590 | lld:lifeskim |
pubmed-article:1138641 | pubmed:issue | 6 | lld:pubmed |
pubmed-article:1138641 | pubmed:dateCreated | 1975-9-9 | lld:pubmed |
pubmed-article:1138641 | pubmed:abstractText | Previous work has documented prolonged survival in dogs subjected to hemorrhagic shock when intra-aortic balloon counter-pulsation (IABC) was instituted in the presence of a 25%-50% reduction in the slope of the left ventricular function curve. Little benefit was noted in the presence of a 75% reduction in slope. In this study, myocardial failure was created in ten dogs by varying periods of hemorrhagic shock. The Endocardial Viability Ratio (EVR) was selected as a method of assessing coronary subendocardial perfusion and was evaluated as a potential method of selecting patients with myocardial failure most likely to benefit from IABC by noting the correlation between EVR and the slope of a simultaneously constructed left ventricular function curve. A significant correlation (r equals .72, p smaller than .001) was noted. The data suggest that a major factor in myocardial failure following hemorrhagic shock is deficient subendocardial coronary perfusion. Variability in data points would make selection of patients on the basis of EVR difficult. | lld:pubmed |
pubmed-article:1138641 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1138641 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1138641 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1138641 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1138641 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1138641 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1138641 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1138641 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1138641 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1138641 | pubmed:language | eng | lld:pubmed |
pubmed-article:1138641 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1138641 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:1138641 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:1138641 | pubmed:month | Jun | lld:pubmed |
pubmed-article:1138641 | pubmed:issn | 0003-4932 | lld:pubmed |
pubmed-article:1138641 | pubmed:author | pubmed-author:FryJJ | lld:pubmed |
pubmed-article:1138641 | pubmed:author | pubmed-author:StarekP JPJ | lld:pubmed |
pubmed-article:1138641 | pubmed:author | pubmed-author:ProctorH JHJ | lld:pubmed |
pubmed-article:1138641 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:1138641 | pubmed:volume | 181 | lld:pubmed |
pubmed-article:1138641 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:1138641 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:1138641 | pubmed:pagination | 893-5 | lld:pubmed |
pubmed-article:1138641 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
pubmed-article:1138641 | pubmed:meshHeading | pubmed-meshheading:1138641-... | lld:pubmed |
pubmed-article:1138641 | pubmed:meshHeading | pubmed-meshheading:1138641-... | lld:pubmed |
pubmed-article:1138641 | pubmed:meshHeading | pubmed-meshheading:1138641-... | lld:pubmed |
pubmed-article:1138641 | pubmed:meshHeading | pubmed-meshheading:1138641-... | lld:pubmed |
pubmed-article:1138641 | pubmed:meshHeading | pubmed-meshheading:1138641-... | lld:pubmed |
pubmed-article:1138641 | pubmed:meshHeading | pubmed-meshheading:1138641-... | lld:pubmed |
pubmed-article:1138641 | pubmed:meshHeading | pubmed-meshheading:1138641-... | lld:pubmed |
pubmed-article:1138641 | pubmed:meshHeading | pubmed-meshheading:1138641-... | lld:pubmed |
pubmed-article:1138641 | pubmed:meshHeading | pubmed-meshheading:1138641-... | lld:pubmed |
pubmed-article:1138641 | pubmed:meshHeading | pubmed-meshheading:1138641-... | lld:pubmed |
pubmed-article:1138641 | pubmed:year | 1975 | lld:pubmed |
pubmed-article:1138641 | pubmed:articleTitle | An investigation of endocardial viability ratio in myocardial failure following prolonged hemorrhagic shock. | lld:pubmed |
pubmed-article:1138641 | pubmed:publicationType | Journal Article | lld:pubmed |